BPC-157 and Teriparatide Interaction

Q: Can I take BPC-157 with Teriparatide?

Yes, BPC-157 and Teriparatide can generally be taken together. Different mechanisms; no known interactions.

Q: Is BPC-157 and Teriparatide safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

Q: What are the interactions between BPC-157 and Teriparatide?

Different mechanisms; no known interactions. This assessment has 90% confidence and is based on documented research data.

Q: How should I time BPC-157 and Teriparatide?

BPC-157 has a half-life of <30 minutes and Teriparatide has a half-life of ~1 hour (subcutaneous); ~5 minutes (intravenous). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Compatible

Researched 90% confidence

BPC-157 and Teriparatide have a compatible interaction with 90% confidence. Different mechanisms; no known interactions. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity

vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic

View full profile

Teriparatide

PTH(1-34) | Bone-Building Anabolic Peptide

Teriparatide binds to PTH type 1 receptors (G-protein coupled receptors) on osteoblasts, osteocytes, and renal tubular cells. This activates PKA and PKC signaling pathways that promote osteoblast activity.

Half-life: ~1 hour (subcutaneous); ~5 minutes (intravenous) Typical dose: 20mcg daily (FDA-approved dose) healing

igf1pth receptor teratogenic

View full profile

Combined Organ Load

Blood Vessels

low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, Teriparatide). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Teriparatide?

Yes, BPC-157 and Teriparatide can generally be taken together. Different mechanisms; no known interactions.

Is BPC-157 and Teriparatide safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Teriparatide?

Different mechanisms; no known interactions. This assessment has 90% confidence and is based on documented research data.

How should I time BPC-157 and Teriparatide?

BPC-157 has a half-life of <30 minutes and Teriparatide has a half-life of ~1 hour (subcutaneous); ~5 minutes (intravenous). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Teriparatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.